Delivery Order SPE2DB22D1202-SPE2DB25FUGK5

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,355.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,604,854 units of Methylphenidate ER 18 mg tablets to support the DLA's medical supply needs. The contract has a period of performance through May 15, 2024 and was awarded on a firm-fixed price basis without any set-aside designations. Amerisourcebergen, a major pharmaceutical...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,070.13, is a Delivery Order under an Indefinite Delivery Contract (IDC) for the supply of a specific medication, Methylphenidate ER 27 mg tablets. The contract has a Firm Fixed Price pricing type and a completion date of December 10, 2024. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,534.32 for the supply of 4566189590 - METHYLPHENIDATE LA 20 MG CAP 100S. The period of performance ends on October 24, 2024. This is a Firm Fixed Price contract with no set-aside requirements, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, valued at $1,118.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylphenidate ER 18 mg tablets, with an ultimate completion date of January 16, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
The federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order from the Defense Logistics Agency (DLA) for $2,308.66 to supply METHYLPHENIDATE ER 36 MG TAB 100S. The award is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to...
This federal contract award, valued at $1,195.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564895313 - METHYLPHENIDATE ER 27 MG TAB 100S, a pharmaceutical product, with a completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, valued at $1,087.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the delivery of 4566736023 ! METHYLPHENIDATE ER 36 MG TAB 100S, with a completion date of December 17, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $8,804.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564945275 | METHYLPHENIDATE ER 18 MG TAB 100S, with a completion date of June 20, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply Methylphenidate ER 27 mg tablets for the Defense Logistics Agency (DLA) Troop Support Medical program. The firm-fixed-price delivery order is valued at $2,528.39 and has a completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of METHYLPHENIDATE ER 54 MG TAB 100S. The contract is a Firm Fixed Price Delivery Order valued at $2,069.94, with an ultimate completion date of August 21, 2024. Amerisourcebergen has been awarded this contract to supply the specified medication to support military treatment facilities and programs. The contract is not set aside for any...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUGK5
    Delivery Order

This federal contract award, valued at $2,568.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566198582 - METHYLPHENIDATE ER 18 MG TAB 100S, with a completion date of October 25, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 1/23/25, 9:32 AM